Seizing Opportunities in Japan the Second Largest Innovation Driven Pharmaceutical Market
October 22, 2018

Japan is and will remain the second largest market for branded pharmaceuticals and innovation. Continued investment in development and commercialization of pharmaceuticals in Japan is creating many opportunities and growing potential for multinational biopharma companies. This is driven in part by ongoing regulatory and government initiatives that reward innovation, shifts in population demographics, and increased disease awareness and identifiable patient populations, amongst other factors. In this webinar IQVIA Japan discusses how to seize these opportunities and the strong potential outlook in the market in the coming years.

Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.

Media Inquiries

Please use this form to reach out to our media team with inquiries. Thank you.